Natick, MA, United States of America

Maria Vilenchik

This inventor holds 4 USPTO granted patents. Top assignee: Hybridon, Inc.. Active years: 1995-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Vilenchik. Retrieved from https://idiyas.com/inventor/maria-vilenchik-t7mqbm8w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Natick, MA (US) (1995 - 1997)
  • Waban, MA (US) (1997)

Company Filing History:


Years Active: 1995-1997

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Maria Vilenchik – Innovator in Oligonucleotide Separation and Detection Technologies

Introduction

Maria Vilenchik, an accomplished inventor based in Natick, Massachusetts, has made significant contributions to the field of biotechnology through her innovative work. With a portfolio of four patents to her name, Vilenchik has focused on advancing methods for separating and detecting oligonucleotides, which are essential components in genetic research and diagnostics.

Latest Patents

Maria Vilenchik's latest patents showcase her expertise in oligonucleotide technologies. One notable patent is for a substrate useful for separating modified oligonucleotides. This substrate incorporates at least 12% polymer in a majority organic solvent, which acts as a denaturing agent. It allows for easy removal from the capillary using low pressure, thus facilitating the separation of unmodified and modified mononucleotides and oligonucleotides.

Another key patent details a method for detecting sub-ppb levels of oligonucleotides in biological fluids. This method involves contacting a biological fluid sample with helper and primer oligonucleotides. If the sample contains a complementary oligonucleotide, a labeled double-stranded molecule is formed, and the presence of this ligation product indicates the target oligonucleotide's existence.

Career Highlights

Maria currently works at Hybridon, Inc., a company dedicated to developing innovative RNA-based therapeutics and diagnostics. Her research and inventions have been pivotal in the advancement of methodologies that enhance sensitivity in oligonucleotide detection, providing valuable tools for scientific and medical applications.

Collaborations

Throughout her career, Maria Vilenchik has collaborated with notable colleagues, including Aharon S Cohen and Alexei Belenky. These partnerships have allowed her to augment her research capabilities and contribute to groundbreaking advancements in the biotechnology sector.

Conclusion

Maria Vilenchik exemplifies the role of a pioneering inventor in the biotechnology landscape. Her patents and contributions significantly propel the understanding and application of oligonucleotide technologies, demonstrating the potential for future innovations in this critical field. As a dedicated researcher, Vilenchik continues to pave the way for advancements that can impact healthcare and scientific research globally.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…